Akihiko Nakaya, Kimihiko Kaneko, Arifumi Matsumoto, Yuki Matsumoto, Yasuhiko Matsumori, & Isao Nagano. (2024). Reversible cerebral vasoconstriction syndrome developed during treatment of Parkinson's disease with rasagiline mesylate: A case report. SAGE Publishing.
Chicago Style (17th ed.) CitationAkihiko Nakaya, Kimihiko Kaneko, Arifumi Matsumoto, Yuki Matsumoto, Yasuhiko Matsumori, and Isao Nagano. Reversible Cerebral Vasoconstriction Syndrome Developed During Treatment of Parkinson's Disease with Rasagiline Mesylate: A Case Report. SAGE Publishing, 2024.
MLA (9th ed.) CitationAkihiko Nakaya, et al. Reversible Cerebral Vasoconstriction Syndrome Developed During Treatment of Parkinson's Disease with Rasagiline Mesylate: A Case Report. SAGE Publishing, 2024.
Warning: These citations may not always be 100% accurate.